Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.

MLA

Zhu, J., et al. “Taraxasterol Inhibits TGF-Β1-Induced Epithelial-to-Mesenchymal Transition in Papillary Thyroid Cancer Cells through Regulating the Wnt/β-Catenin Signaling.” Human & Experimental Toxicology, vol. 40, no. 12_suppl, Dec. 2021, pp. S87–95. EBSCOhost, https://doi.org/10.1177/09603271211023792.

APA

Zhu, J., Li, X., Zhang, S., Liu, J., Yao, X., Zhao, Q., Kou, B., Han, P., Wang, X., Bai, Y., Zheng, Z., & Xu, C. (2021). Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling. Human & Experimental Toxicology, 40(12_suppl), S87–S95. https://doi.org/10.1177/09603271211023792

Chicago

Zhu, J, X Li, S Zhang, J Liu, X Yao, Q Zhao, B Kou, et al. 2021. “Taraxasterol Inhibits TGF-Β1-Induced Epithelial-to-Mesenchymal Transition in Papillary Thyroid Cancer Cells through Regulating the Wnt/β-Catenin Signaling.” Human & Experimental Toxicology 40 (12_suppl): S87–95. doi:10.1177/09603271211023792.